Comparison of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: Experimental study with rabbits

Journal of Magnetic Resonance Imaging

Volumn 22, Issue 3, 2005, Pages 361-367

  Zhou, Zhengyang ^a   Guo, Jian ^b   Yu, Haiping ^a   Zhu, Bin ^a   Liu, Changjian ^a   Jiang, Xiqun ^b   Zhang, Ming ^a   Chen, Junkun ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Comparative studies; Contrast agents; Gadolinium; Lymph node; MR lymphography; Visible size

Indexed keywords

GADODIAMIDE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE BIS(2 AMINOETHOXY)ETHANE; KETAMINE; UNCLASSIFIED DRUG; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEVICE; LYMPHOGRAPHY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING;

ANIMALS; CONTRAST MEDIA; GADOLINIUM DTPA; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; PENTETIC ACID; POLYETHYLENE GLYCOLS; RABBITS;

EID: 24744439499     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20395     Document Type: Article

References (27)

1. Weissleder R, Elizondo G, Wittenberg J, et al. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990;175:489-493.
2. Weissleder R, Heautot JF, Schaffer BK, et al. MR lymphography: study of a high efficiency lymphotropic agent. Radiology 1994;191: 225-230.
3. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. New Engl J Med 2003;348:2491-2499.
4. Misselwitz B, Platzek J, Raduchel B, et al. Gadofluorine 8 initial experience with a new contrast medium for interstitial MR lymphography. MAGMA 1999;8:190-195.
5. Shimada M, Yoshikawa K, Suganuma T, et al. Interstitial magnetic resonance lymphography: comparative animal study of gadofluorine 8 and gadolinium diethylenetriamine-pentaacetic acid. J Comput Assist Tomogr 2003;27:641-646.
6. Staatz G, Nolte-Ernsting CC, Adam GB, et al. Interstitial T1- weighted MR lymphography: lipophilic perfluorinated gadolinium chelates in pigs. Radiology 2001;220:129-134.
7. Herborn CU, Vogt FM, Lauenstein TC, et al. Assessment of normal, inflammatory, and tumor-bearing lymph nodes with contrast-enhanced Interstitial magnetic resonance lymphography: preliminary results in rabbits. J Magn Reson Imaging 2003;18:328-335.
8. Herborn CH, Lauenstein TC, Vogt FM, et al. Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model. AJR AM J Roentgenol 2002; 179:1567-1572.
9. Misselwitz B, Schmitt-Willich H, Michaelis M, Oellinger JJ. Interstitial magnetic resonance lymphography using a polymeric t1 contrast agent: initial experience with Gadomer-17. Invest Radiol 2002;37:146-151.
10. Torchia MG, Misselwitz B. Combined MR lymphangiography and MR imaging-guided needle localization of sentinel lymph nodes using Gadomer-17. AJR Am J Roentgenol 2002;179:1561-1565.
11. Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW. Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res 2003;63:271-276.
12. Harika L, Weissleder R, Poss K, Zimmer C, Papisov MI, Brady TJ. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM. Magn Reson Med 1995;33:88-92.
13. Misselwitz B, Sachse A. Interstitial MR lymphography using Gd-carrying liposomes. Acta Radiol Suppl 1997;412:51-55.
14. Fujimoto Y, Okuhata Y, Tyngi S, Namba Y, Oku N. Magnetic resonance lymphography of profundus lymph nodes with liposomal gadolinium- diethylenetriamine pentaacetic acid. Biol Pharm Bull 2000;23:97-100.
15. Desser TS, Rubin DL, Muller H, McIntire GL, Bacon ER, Hollister R. Interstitial MR and CT lymphography with Gd-DTPA-co-alpha, omega- diaminoPEG(1450) and Gd-DTPA-co- 1,6-diaminohexane polymers: preliminary experience. Acad Radiol 1999;6:112-118.
16. Ruehm SG, Corot C, Debatin JF, et al. Interstitial MR lymphography with a conventional extracellular gadolinium-based agent: assessment in rabbits. Radiology 2001;218:664-669.
17. Ruehm SG, Schroeder T, Debatin JF, et al. Interstitial MR lymphography with gadoterate meglumine: initial experience in humans. Radiology 2001;220:816-821.
18. Suga K, Yuan Y, Ogasawara N, Okada M, Matsunaga N. Localization of breast sentinel lymph nodes by MR lymphography with conventional gadolinium contrast agent: preliminary observations in dogs and humans. Acta Radiol 2003;44:35-42.
19. Fink C, Bock M, Kiessling F, Delorme S. Interstitial magnetic resonance lymphography with gadobutrol in rats: evaluation of contrast kinetics. Invest Radiol 2002;37:655-662.
20. Unger EC, Shen DK, Wu GL, Stewart L, Matsunaga TO, Trouard TP. Gadolinium-containing copolymeric chelates - a new potential MR contrast agent. MAGMA 1999;8:154-162.
21. Ladd DL, Hollister R, Peng X, et al. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties. Bioconjugate Chem 1999;10:361-370.
22. Mohr U, Weissleder R. Lymph node diagnosis with imaging methods: an overview with special reference to recent developments in the area of MR media. Z Lymphol 1996;20:15-20.
23. Vinnicombe SJ, Norman AR, Nicolson V, Husband JE. Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography. Radiology 1995;194:349-355.
24. Steckel RJ, Cameron TP. Changes in lymph node size induced by lymphangiography. Radiology 1966;87:753-755.
25. Koehler PF, Potchen EJ, Cole WR, Studer R. Experimental studies of intralymphatic administration of radiotherapy. Radiology 1968; 90:495-501.
26. Runge V, Dickey KM, Williams NM, et al. Local tissue toxicity in response to extravascular extravasation of magnetic resonance contrast media. Invest Radiol 2002;37:393-398.
27. Suga K, Yuan Y, Ogasawara N, Okada M, Matsunaga N. Visualization of normal and interrupted lymphatic drainage in dog legs with interstitial MR lymphography using an extracellular MR contrast agent, gadopentetate dimeglumine. Invest Radiol 2003;38:349-357.